AstraZeneca reports disappointing Phase 3 data for lung cancer ADC (NASDAQ:AZN)
IvelinRadkov AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo (OTCPK:DSKYF) (OTCPK:DSNKY) stated {that a} Part 3 research of their antibody drug conjugate, or ...
Tag: ADC
